Clinical Trial Update: Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating pharmacogenetics of risperidone in children with pervasive developmental disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Child Development Disorders, Pervasive | Phase 1, Phase 2 | Status: COMPLETED